Papers by Yijun Du · AgingResearch.News

European Journal of Pharmacology17 Aug
Glucagon-like peptide-1 receptor agonist dulaglutide attenuates liver injury in metabolic dysfunction-associated steatotic liver disease with diabetic mice
Experiments in animalsInterventions
Paper
ADA Scientific Sessions 2026 Abstract5 Jun
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZT006 Tablet, an Oral GLP-1 Receptor Agonist Peptide, in Healthy Participants, Participants with Overweight or Obesity: A Phase 1 Study
Trial in peopleInterventions
Paper
ADA Scientific Sessions 2025 Abstract13 Jun
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS9531 Tablet, an Oral Dual GLP-1/GIP Receptor Agonist, in Healthy Participants—A Phase 1 Study
Trial in peopleInterventions
Paper
ADA Scientific Sessions 2025 Abstract13 Jun
Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of a Dual GLP-1/GIP Receptor Agonist (HDM1005)—A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Dose-Escalation Study
Trial in peopleInterventions
Paper